Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Reply to ‘CD123 Immunohistochemistry for Plasmacytoid Dendritic Cells Is Useful in the Diagnosis of Scarring Alopecia’: Three PDC-Related Parameters Are Useful in Differentiating Lupus Alopecia from LPP

research Reply to ‘CD123 immunohistochemistry for plasmacytoid dendritic cells is useful in the diagnosis of scarring alopecia’: three PDC-related parameters are useful in differentiating lupus alopecia from LPP

4 citations , November 2016 in “Journal of Cutaneous Pathology”

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

research Lupus erythematosus: systemic and cutaneous manifestations

144 citations , September 2006 in “Clinics in Dermatology”

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

research Friend or foe: A systematic review of dupilumab and alopecia areata

4 citations , May 2025 in “Journal of the American Academy of Dermatology”

Topical Immunotherapy With Diphenylcyclopropenone in Different Types of Alopecia Areata: Association With Clinical Parameters and a Functional Gene Polymorphism of the Interleukin-6 Promoter

research Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors

January 2005 in “Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München)”

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Efficacy of Betamethasone Valerate Foam Formulation in Comparison with Betamethasone Dipropionate Lotion in the Treatment of Mild-to-Moderate Alopecia Areata: A Multicenter, Prospective, Randomized, Controlled, Investigator-Blinded Trial

research Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild‐to‐moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator‐blinded trial

66 citations , July 2003 in “International Journal of Dermatology”

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The Allegro Phase 2b/3 Randomized Clinical Trial

research Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial

4 citations , October 2024 in “American Journal of Clinical Dermatology”

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

research Flurandrenolide

January 2004

Alopecia Universalis After Alemtuzumab Treatment for Multiple Sclerosis: A Two-Year Follow-Up of Two Patients

research Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients

3 citations , July 2021 in “International journal of environmental research and public health/International journal of environmental research and public health”

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Case Report: Repigmentation and Complete Hair Regrowth in an 11-Year-Old Preadolescent with Alopecia Totalis Treated with a JAK Inhibitor

research Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor

July 2026 in “Frontiers in Pediatrics”

An 11-year-old girl with severe hair loss regrew and repigmented her hair after JAK inhibitor treatment.

research Carbon‐dioxide laser‐associated PDT treatment of folliculitis decalvans

1 citations , March 2024 in “International Journal of Dermatology”

CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.

← Previous page